David M. Patrick
Impact in
-
- Antibiotic Use and Resistance
- Epidemiology top 1%
- HIV, Drug Use, Sexual Risk
- Influenza Virus Research Studies
- Herpesvirus Infections and Treatments
- Cervical Cancer and HPV Research
Papers in
- Epidemiology 47
- Influenza Virus Research Studies 12
- Pneumonia and Respiratory Infections 10
- Herpesvirus Infections and Treatments 9
-
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 6
- HIV/AIDS Research and Interventions 5
- Co-authors
- Michael L. Rekart (12 shared papers)Steffanie A. Strathdee (5 shared papers)Martin T. Schechter (4 shared papers)Peter Cornelisse (3 shared papers)Sue L. Currie (3 shared papers)Fawziah Marra (17 shared papers)Julio S. G. Montaner (1 shared paper)Michael V O'Shaughnessy (1 shared paper)
- Journals
- Clinical Infectious Diseases (7 papers)Vaccine (5 papers)PLoS ONE (5 papers)Canadian Journal of Public Health (5 papers)Canadian Medical Association Journal (4 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
David M. Patrick
120 papers receiving 4.2k citations
David M. Patrick's Hit Papers
Peers
Comparison fields: 5 of 122
- Applied Microbiology and Biotechnology 171
- Epidemiology 2.1k
- Infectious Diseases 732
- Microbiology 153
- Hepatology 204
Countries citing papers authored by David M. Patrick
This map shows the geographic impact of David M. Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Patrick more than expected).
Fields of papers citing papers by David M. Patrick
This network shows the impact of papers produced by David M. Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Patrick. The network helps show where David M. Patrick may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Patrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Needle exchange is not enough Hit paper breakdown → | 1997 | 570 |
| 2 | 2010 | 261 | |
| 3 | 2009 | 241 | |
| 4 | Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. | 2001 | 184 |
| 5 | 1999 | 148 | |
| 6 | 2007 | 143 | |
| 7 | 2006 | 133 | |
| 8 | 2006 | 124 | |
| 9 | 2009 | 119 | |
| 10 | 2009 | 119 | |
| 11 | 2022 | 111 | |
| 12 | 2010 | 108 | |
| 13 | 2010 | 87 | |
| 14 | 2003 | 85 | |
| 15 | 2010 | 68 | |
| 16 | 2004 | 64 | |
| 17 | 1998 | 61 | |
| 18 | 2003 | 60 | |
| 19 | 2017 | 52 | |
| 20 | 2001 | 50 |
About David M. Patrick
David M. Patrick is a scholar working on Epidemiology, Infectious Diseases, Applied Microbiology and Biotechnology, Hepatology and Public Health, Environmental and Occupational Health, having authored 121 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (13 papers), Influenza Virus Research Studies (12 papers), Pneumonia and Respiratory Infections (10 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Herpesvirus Infections and Treatments (9 papers), COVID-19 Clinical Research Studies (6 papers), HIV/AIDS Research and Interventions (5 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (171 citations), Epidemiology (2.1k citations), Infectious Diseases (732 citations), Microbiology (153 citations) and Hepatology (204 citations). David M. Patrick has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Michael L. Rekart, Steffanie A. Strathdee, Martin T. Schechter, Peter Cornelisse, Sue L. Currie, Fawziah Marra, Julio S. G. Montaner, Michael V O'Shaughnessy, Danuta M. Skowronski and Carlo A. Marra. Their work appears in journals such as Clinical Infectious Diseases, Vaccine, PLoS ONE, Canadian Journal of Public Health and Canadian Medical Association Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.